IBS Medications Linked to Death Risk

A large, long-term study led by Cedars-Sinai Medical Center investigators suggests that some medications commonly prescribed for Irritable Bowel Syndrome (IBS), including antidepressants and opioid-based antidiarrheal drugs like loperamide and diphenoxylate, may be associated with an increased risk of death. The study, based on nearly two decades of electronic health records from over 650,000 U.S. adults with IBS, found that long-term antidepressant use was associated with a 35% higher risk of death, and loperamide and diphenoxylate use with roughly double the risk. Ali Rezaie, a senior author, emphasized that while the individual risk is small, patients should discuss treatment options with their healthcare providers. The study calls for more research and personalized approaches to IBS care, potentially influencing future treatment guidelines and the pharmaceutical industry.